[MET-PET in low-grade glioma. Safe way to follow disease progression and treatment].
Smits
Anja
A
Neurocentrum, enheten för neurologi. anja.smits@neurologi.uu.se
Savitcheva
Irina
I
Ribom
Dan
D
D000328:Adult; D001254:Astrocytoma / Q000000981:diagnostic imaging / Q000401:mortality / Q000532:radiotherapy; D001932:Brain Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000532:radiotherapy; D002250:Carbon Radioisotopes; D018450:Disease Progression; D005910:Glioma / Q000000981:diagnostic imaging* / Q000401:mortality / Q000532:radiotherapy; D006801:Humans; D008715:Methionine; D009837:Oligodendroglioma / Q000000981:diagnostic imaging / Q000401:mortality / Q000532:radiotherapy; D049268:Positron-Emission Tomography / Q000379:methods*; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D002250:Carbon Radioisotopes; D008715:Methionine